Hikma Pharmaceutical | HIK - Current Assets

Stock Price
1,308.00
Daily Change
21.00 1.63%
Monthly
4.89%
Yearly
-33.09%
Q2 Forecast
1,279.62

Hikma Pharmaceutical reported $2.64B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Almirall EUR 713.98M 69K Dec/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Autolus Therapeutics Ltd USD 435.92M 78.66M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Orion EUR 1.34B 247.2M Dec/2025
Recordati EUR 1.71B 144.32M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 6.05B 733M Dec/2025